Benzinga | Nov 10, 2021 05:42PM EST

RxSight Q3 EPS $(0.65) Misses $(0.62) Estimate, Sales $5.79M Beat $5.22M Estimate

RxSight (NASDAQ:RXST) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.62) by 4.84 percent. The company reported quarterly sales of $5.79 million which beat the analyst consensus estimate of $5.22 million by 10.84 percent.